Gregory J Carven (George Soder)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Vascular Smooth Muscle Cells

Top Venues

Science signaling

Science translational medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Justin W Jackson, Frederick C Streich, Ajai Pal, George Coricor, Christopher Boston, Christopher T Brueckner, Kaleigh Canonico, Christopher Chapron, Shaun M Cote, Kevin B Dagbay, Francis T Danehy, Mania Kavosi, Sandeep Kumar, Susan Lin, Christopher Littlefield, Kailyn Looby, Rohan Manohar, Constance J Martin, Marcie Wood, Agatha Zawadzka, Stefan Wawersik, Samantha B Nicholls, Abhishek Datta, Alan Buckler, Thomas Schürpf, Gregory J Carven, Mohammed Qatanani, Adam I Fogel
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Science signaling 17 (844) (2024)
Justin W Jackson, Frederick C Streich, Ajai Pal, George Coricor, Christopher Boston, Christopher T Brueckner, Kaleigh Canonico, Christopher Chapron, Shaun M Cote, Kevin B Dagbay, Francis T Danehy, Mania Kavosi, Sandeep Kumar, Susan Lin, Christopher Littlefield, Kailyn Looby, Rohan Manohar, Constance J Martin, Marcie Wood, Agatha Zawadzka, Stefan Wawersik, Samantha B Nicholls, Abhishek Datta, Alan Buckler, Thomas Schürpf, Gregory J Carven, Mohammed Qatanani, Adam I Fogel
An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis. Science signaling 17 (844) (2024)
Constance J Martin, Abhishek Datta, Christopher Littlefield, Ashish Kalra, Christopher Chapron, Stefan Wawersik, Kevin B Dagbay, Christopher T Brueckner, Anastasia Nikiforov, Francis T Danehy, Frederick C Streich, Christopher Boston, Allison Simpson, Justin W Jackson, Susan Lin, Nicole Danek, Ryan R Faucette, Pichai Raman, Allan D Capili, Alan Buckler, Gregory J Carven, Thomas Schürpf
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape. Science translational medicine 12 (536) (2021)
Beth Hutchins, Gary C Starling, Mark A McCoy, Danuta Herzyk, Frederique M Poulet, John Dulos, Liming Liu, Soonmo Peter Kang, Laurence Fayadat-Dilman, Mark Hsieh, Christine L Andrews, Gulesi Ayanoglu, Constance Cullen, Rene de Waal Malefyt, Robert A Kastelein, Sabine Le Saux, Julie Lee, Sophie Li, Dan Malashock, Svetlana Sadekova, Gregory J Carven, Hans van Eenennaam, Aarron Willingham, Ying Yu, Michel Streuli, Andrea van Elsas
Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab. Molecular cancer therapeutics 19 (6) (2020)
James R Apgar, Amy S P Tam, Rhady Sorm, Sybille Moesta, Amy C King, Han Yang, Kerry Kelleher, Denise Murphy, Aaron M D'Antona, Guoying Yan, Xiaotian Zhong, Linette Rodriguez, Weijun Ma, Darren E Ferguson, Gregory J Carven, Eric M Bennett, Laura Lin
Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design. PloS one 15 (5) (2020)